Development of an NGS-based ecDNA Detection Solution into a Clinical Trial Device Targeting Oncogene Amplification
Time: 3:10 pm
day: Day Two Track A
Details:
- Delve into the development and validation path to transform access to innovative precision therapies
- Learn about SOPHiA GENETICS’ unique ability to harmonize data derived from diverse genomic instruments and deploy as a robust, standardized solution enabling a decentralized model for clinical trial testing
- Hear how the integration of ecDNA technology will impact the journey of patients with oncogene-amplified cancers
